|Articles|February 10, 2023
SCOPE 2023: Beat AML Master Trial Successes
Author(s)Lisa Henderson
Len Rosenberg, head of clinical operations at Beat AML, discusses the outcome of his company's study, which was four years in the making.
Advertisement
In an interview at the 2023 SCOPE conference with ACT Editor-in-Chief, Lisa Henderson, Len Rosenberg, head of clinical operations at Beat AML, updates the public on the trial results (which he was a lead author of) and how the use of precision medicine guidelines played a role.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: Targeted Trial Growth, Site Startup Strains, and Leadership Shake-Up at FDA
2
How the FDA’s CNPV Program Is Reshaping Trial Operations and Accelerated Review Strategies
3
Former FDA Commissioners Warn New Vaccine Policies Could Undermine Longstanding Regulatory Framework
4
Voyxact Lands FDA Accelerated Approval Following Positive Results in Phase III VISIONARY Trial
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
